Insider Trading activities of Gtc Biotherapeutics Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Gtc Biotherapeutics Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Gtc Biotherapeutics Inc since year 2005. Table 2 shows the detailed insider transactions of Gtc Biotherapeutics Inc since 2005. The reporting company's ticker symbol is GTCB. The reporting company's CIK number is 904973.
The total value of stock buying since 2005 is $16,278,019.
The total value of stock sales since 2005 is $67,657.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Gtc Biotherapeutics Inc (GTCB).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2010-02 14,798 $15,981 0 $0 0 $0
2010-01 0 $0 14,798 $16,647 0 $0
2009-11 3,387,851 $3,625,000 0 $0 0 $0
2008-11 86,000 $13,760 0 $0 0 $0
2008-03 100,400 $48,192 39,930 $22,691 0 $0
2008-02 4,036,808 $3,512,022 0 $0 0 $0
2007-12 44,565 $39,418 0 $0 0 $0
2007-08 14,200 $14,554 0 $0 0 $0
2007-03 24,000 $24,000 0 $0 0 $0
2007-01 7,260,000 $8,929,800 0 $0 0 $0
2006-12 0 $0 7,500 $8,220 0 $0
2006-11 14,300 $15,158 0 $0 0 $0
2006-09 3,421 $4,242 0 $0 0 $0
2006-03 0 $0 20,000 $20,099 0 $0
2005-11 3,000 $4,824 0 $0 0 $0
2005-06 2,000 $2,680 0 $0 0 $0
2005-05 9,000 $10,125 0 $0 0 $0
2005-03 10,300 $18,263 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Gtc Biotherapeutics Inc insiders (GTCB)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2010-02-09 Scotland Richard A (Senior VP, Regulatory Affairs) Buy 14,798 1.08 15,981
2010-01-19 Scotland Richard A (Senior VP, Regulatory Affairs) Sale 14,798 1.12 16,647
2009-11-02 Lfb Biotechnologies S.a.s.u. (Director by Deputization) Buy 3,387,851 1.07 3,625,000
2008-11-21 Cox Geoffrey F (President, CEO and Chairman) Buy 86,000 .16 13,760
2008-03-14 Cox Geoffrey F (President, CEO and Chairman) Buy 100,400 .48 48,192
2008-03-12 Liposky Gregory F (Senior VP, Operations) Sale 22,930 .57 13,001
2008-03-12 Woloshen Daniel S (Senior VP and General Counsel) Sale 17,000 .57 9,690
2008-02-12 Bechon Christian Buy 2,018,404 .87 1,756,011
2008-02-12 Lfb Biotechnologies S.a.s.u. Buy 2,018,404 .87 1,756,011
2007-12-17 Gray Mary Ann (Director) Buy 10,000 .88 8,800
2007-12-17 Woloshen Daniel S (Senior VP and General Counsel) Buy 1,200 .89 1,068
2007-12-14 Green John B (Senior VP and CFO) Buy 1,500 .89 1,333
2007-12-14 Liposky Gregory F (Senior VP, Operations) Buy 1,100 .87 957
2007-12-14 Meade Harry (SVP, Transgenic Research) Buy 10,000 .90 9,000
2007-12-14 Geraghty James A (Director) Buy 10,000 .87 8,690
2007-12-13 Cox Geoffrey F (President, CEO and Chairman) Buy 10,765 .89 9,570
2007-08-13 Cox Geoffrey F (President, CEO and Chairman) Buy 14,200 1.02 14,554
2007-03-14 Cox Geoffrey F (President, CEO and Chairman) Buy 24,000 1.00 24,000
2007-01-03 Bechon Christian Buy 3,630,000 1.23 4,464,900
2007-01-03 Lfb Biotechnologies S.a.s.u. Buy 3,630,000 1.23 4,464,900
2006-12-22 Woloshen Daniel S (Senior VP and General Counsel) Sale 7,500 1.10 8,220
2006-11-06 Cox Geoffrey F (President, CEO and Chairman) Buy 14,300 1.06 15,158
2006-09-29 Geraghty James A (Director) Buy 2,621 1.24 3,250
2006-09-29 Tuck Alan W (Director) Buy 800 1.24 992
2006-03-17 Liposky Gregory F (Senior VP, Operations) Sale 20,000 1.00 20,099
2005-11-11 Geraghty James A (Director) Buy 3,000 1.61 4,824
2005-06-01 Tuck Alan W (Director) Buy 2,000 1.34 2,680
2005-05-16 Green John B (SVP and CFO) Buy 1,000 1.39 1,390
2005-05-16 Geraghty James A (Director) Buy 3,000 1.32 3,960
2005-05-04 Cox Geoffrey F (President, CEO and C) Buy 5,000 .96 4,775
2005-03-15 Cox Geoffrey F (President, CEO and C) Buy 5,300 1.80 9,513
2005-03-14 Geraghty James A (Director) Buy 5,000 1.75 8,750

Insider trading activities including stock purchases, stock sales, and option exercises of GTCB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Gtc Biotherapeutics Inc (symbol GTCB, CIK number 904973) see the Securities and Exchange Commission (SEC) website.